Glaucoma is defined by a typical optic neuropathy accompanied by characteristic visual field
loss and eventual blindness. The major risk factor for glaucoma is elevated intraocular …

Intraocular pressure (IOP) lowering drugs that are approved for the treatment of glaucoma
and ocular hypertension have limited activity on increasing aqueous humor movement …

Introduction: Glaucoma is a disease of the eye in which the optic nerve and retinal ganglion
cells (RGCs) are injured, leading to the loss of the peripheral visual field and eventually to …

Classic glaucoma treatment focuses on intraocular pressure (IOP) reduction. Better
knowledge of the pathogenesis of the disease has opened up new therapeutical …

Glaucoma is a potentially blinding disease. The goal of glaucoma therapy is to reduce
intraocular pressure to a predetermined target level. There are currently 5 classes of …

Elevated IOP in clinical practice is usually seen in glaucoma or ocular hypertension.
Glaucoma affects 60 million people worldwide and 8.4 million are bilaterally blind from this …

Glaucoma is a long-term ocular neuropathy defined by optic disc or retinal nerve fiber
structural abnormalities and visual field abnormality. Primary open-angle glaucoma is the …

Glaucoma comprises a group of progressive, neurodegenerative disorders characterized by
retinal ganglion cell death and nerve fiber layer atrophy. Several randomized controlled …

Introduction Glaucoma, a neuropathy characterized by increased intraocular pressure (IOP),
is the major cause of blindness worldwide and its treatment aims at reducing IOP. Areas …

Introduction: In the last decades, the therapy of glaucoma has largely shifted from surgery to
medical treatment thanks to the introduction of strongly effective formulations, that is …